SCHEMBL8387341

SCHEMBL8387341

CC(=O)c1ccc2c([nH]c3ccccc32)c1C

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KIF11 P52732 4/20 0.50
MAPT P10636 3/20 0.50
MAPK1 P28482 2/20 0.50
NPSR1 Q6W5P4 2/20 0.50
PIM3 Q86V86 2/20 0.49
PIM1 P11309 1/20 0.49
PBRM1 Q86U86 2/20 0.47
PARP14 Q460N5 2/20 0.47
MPL P40238 2/20 0.46
GABRP O00591 2/20 0.45
GABRD O14764 2/20 0.45
GABRA1 P14867 2/20 0.45
GABRB1 P18505 2/20 0.45
GABRG2 P18507 2/20 0.45
GABRB3 P28472 2/20 0.45
GABRA5 P31644 2/20 0.45
GABRA3 P34903 2/20 0.45
GABRA2 P47869 2/20 0.45
GABRB2 P47870 2/20 0.45
GABRA4 P48169 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31124833 1.00 KIF11 (0.50) KIF11MAPTMAPK1NPSR1PIM3
SCHEMBL8389062 0.87 MPL (0.56) KIF11MAPTMAPK1NPSR1PIM3
SCHEMBL2333357 0.84 PIM3 (0.49) KIF11MAPTMAPK1NPSR1PIM3
SCHEMBL30583772 0.84 PIM3 (0.49) KIF11MAPTMAPK1NPSR1PIM3
SCHEMBL159997 0.81 PBRM1 (0.57) KIF11MAPTMAPK1NPSR1PIM3
SCHEMBL8387303 0.81 KDM4E (0.59) MAPTMAPK1NPSR1GABRPGABRD
Acetic Acid SCHEMBL11537832 0.79 MPL (0.51) KIF11MAPTMAPK1NPSR1PIM3
SCHEMBL9056003 0.77 SLC22A6 (0.51) KIF11MAPTMAPK1NPSR1PIM3
SCHEMBL5964419 0.76 KIF11 (0.56) KIF11MAPTMAPK1NPSR1PARP14
SCHEMBL29726990 0.75 KIF11 (0.66) KIF11MAPTMAPK1NPSR1GABRP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5877199-A ALZHEIMER'S DISEASE; SEDATIVE SANKYO COMPANY, LIMITED (JP) 1999-03-02 US disclosed
CN-1166169-A Heterocyclic compounds, useful as allosteric effectors at muscarinic receptors SANKYO CO (JP) 1997-11-26 CN disclosed
EP-0804416-A1 HETEROCYCLIC COMPOUNDS, USEFUL AS ALLOSTERIC EFFECTORS AT MUSCARINIC RECEPTORS SANKYO COMPANY LIMITED (JP) 1997-11-05 EP disclosed
WO-1996003377-A1 HETEROCYCLIC COMPOUNDS, USEFUL AS ALLOSTERIC EFFECTORS AT MUSCARINIC RECEPTORS SANKYO COMPANY, LIMITED (JP) 1996-02-08 WO disclosed